Clinical Pharmacokinetics and Pharmacodynamics of Propofol
Open accessThe DOI matches its Crossref record; 197 of the 201 references it cites were found in a registry or an index.
Abstract
receptor, and has gained widespread use due to its favourable drug effect profile. The main adverse effects are disturbances in cardiopulmonary physiology. Due to its narrow therapeutic margin, propofol should only be administered by practitioners trained and experienced in providing general anaesthesia. Many pharmacokinetic (PK) and pharmacodynamic (PD) models for propofol exist. Some are used to inform drug dosing guidelines, and some are also implemented in so-called target-controlled infusion devices, to calculate the infusion rates required for user-defined target plasma or effect-site concentrations. Most of the models were designed for use in a specific and well-defined patient category. However, models applicable in a more general population have recently been developed and published. The most recent example is the general purpose propofol model developed by Eleveld and colleagues. Retrospective predictive performance evaluations show that this model performs as well as, or even better than, PK models developed for specific populations, such as adults, children or the obese; however, prospective evaluation of the model is still required. Propofol undergoes extensive PK and PD interactions with both other hypnotic drugs and opioids. PD interactions are the most clinically significant, and, with other hypnotics, tend to be additive, whereas interactions with opioids tend to be highly synergistic. Response surface modelling provides a tool to gain understanding and explore these complex interactions. Visual displays illustrating the effect of these interactions in real time can aid clinicians in optimal drug dosing while minimizing adverse effects. In this review, we provide an overview of the PK and PD of propofol in order to refresh readers' knowledge of its clinical applications, while discussing the main avenues of research where significant recent advances have been made.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A General Model for the Origin of Allometric Scaling Laws in Biology
West, G. B., Brown, J. H., & Enquist, B. J. (1997) · Science · doi:10.1126/science.276.5309.122 · Cited by 5,016
Brain stem reticular formation and activation of the EEG
Moruzzi, G., & Magoun, H. W. (1949) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(49)90219-9 · Cited by 4,307
Jevtovic-Todorovic, V., Hartman, R. E., Izumi, Y., Benshoff, N. D., Dikranian, K., Zorumski, C. F., Olney, J. W., & Wozniak, D. F. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-03-00876.2003 · Cited by 1,983
An information integration theory of consciousness
Tononi, G. (2004) · BMC Neuroscience · doi:10.1186/1471-2202-5-42 · Cited by 1,958
The sleep switch: hypothalamic control of sleep and wakefulness
Saper, C. B., Chou, T. C., & Scammell, T. E. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02002-6 · Cited by 1,656
Breakdown of cortical effective connectivity during sleep
Massimini, M., Ferrarelli, F., Huber, R., Esser, S. K., Singh, H., & Tononi, G. (2005) · Science · doi:10.1126/science.1117256 · Cited by 1,534
A Primer for EEG Signal Processing in Anesthesia
Rampil, I. J. (1998) · Anesthesiology · doi:10.1097/00000542-199810000-00023 · Cited by 1,503
Berenbaum, M. C. (1989) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00026-2 · Cited by 1,414
Saper, C. B., Fuller, P. M., Pedersen, N. P., Lu, J., & Scammell, T. E. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.032 · Cited by 1,404
General Anesthesia, Sleep, and Coma
Brown, E. N., Lydic, R., & Schiff, N. D. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0808281 · Cited by 1,350
Research works printed but not linked: 5
- Glen JB James R 2,6-Diisopropylphenol as an anaesthetic agent 1977 London United States Patent and Trademark Office 1 10
- Schüttler J Schwilden H Modern anesthetics (handbook of experimental pharmacology) 2008 Heidelberg Springer
- Pubchem. Propofol. 2017. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/propofol#section=Top.
- Hardman JG Hopkins PM Struys MMR Oxford textbook of anaesthesia 2017 Oxford Oxford University Press
- Ure RW Dwyer SJ Blogg CE White AP Patient-controlled anxiolysis with propofol Br J Anaesth 1991 67 857P 858P
Cited by
Items 701–800 of 890
Development and Validation of a Chinese Obesity-Specific Physiological Database for PBPK Modeling
Yang, R., Wen, Y., Zhang, S., Yang, G., Zhu, L., & Pei, Q. (2025) · Clinical Pharmacokinetics · doi:10.1007/s40262-025-01605-1
“About 70% of the drug is converted to propofol glucuronide by UGT, about 29% is hydroxylated (mainly CYP2B6 and CYP2C9), and the metabolites are excreted mainly in the urine [24].”
Yang, Y., Lang, Z., Wang, X., Yang, P., Meng, N., Xing, Y., & Liu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26741876
Yang, Y., Lang, Z., Wang, X., Yang, P., Meng, N., Xing, Y., & Liu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26741879
Yang, Y., Lang, Z., Wang, X., Yang, P., Meng, N., Xing, Y., & Liu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26157239
Yang, Y., Lang, Z., Wang, X., Yang, P., Meng, N., Xing, Y., & Liu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26741873
Wilhelms, B. (2024) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-34887
Chen, B., Yin, X.-Y., Jiang, L.-H., Liu, J.-H., Shi, Y.-Y., & Yuan, B.-Y. (2022) · Figshare · doi:10.6084/m9.figshare.20430560
Wu, X., Liao, M., Lin, X., Hu, J., Zhao, T., & Sun, H. (2024) · Figshare · doi:10.6084/m9.figshare.24934138
Wu, X., Liao, M., Lin, X., Hu, J., Zhao, T., & Sun, H. (2024) · Figshare · doi:10.6084/m9.figshare.24934504
Zeng, W., Deng, Z., Gao, Y., Sun, G., Li, X., & Yuan, D. (2023) · Figshare · doi:10.6084/m9.figshare.23597485
Yang, Y., Lang, Z., Wang, X., Yang, P., Meng, N., Xing, Y., & Liu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26741885
Yang, Y., Lang, Z., Wang, X., Yang, P., Meng, N., Xing, Y., & Liu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26741846
Yang, Y., Lang, Z., Wang, X., Yang, P., Meng, N., Xing, Y., & Liu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26741855
Yang, Y., Lang, Z., Wang, X., Yang, P., Meng, N., Xing, Y., & Liu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26741840
Yang, Y., Lang, Z., Wang, X., Yang, P., Meng, N., Xing, Y., & Liu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26157560
Yang, Y., Lang, Z., Wang, X., Yang, P., Meng, N., Xing, Y., & Liu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26741849
Yang, Y., Lang, Z., Wang, X., Yang, P., Meng, N., Xing, Y., & Liu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26741852
Yang, Y., Lang, Z., Wang, X., Yang, P., Meng, N., Xing, Y., & Liu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26741837
Su, D., Zhang, W., Li, J., Tan, X., Wei, H., Wang, Y., & Ji, Z. (2024) · Figshare · doi:10.6084/m9.figshare.26666767
Yang, Y., Lang, Z., Wang, X., Yang, P., Meng, N., Xing, Y., & Liu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26741888
Yang, Y., Lang, Z., Wang, X., Yang, P., Meng, N., Xing, Y., & Liu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26741882
Huang, Y., Yan, T., Lu, G., Luo, H., Lai, Z., & Zhang, L. (2023) · Figshare · doi:10.6084/m9.figshare.24797852
Yang, Y., Lang, Z., Wang, X., Yang, P., Meng, N., Xing, Y., & Liu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26741864
Yang, Y., Lang, Z., Wang, X., Yang, P., Meng, N., Xing, Y., & Liu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26741858
Wang, J., Wang, X., Liu, H., & 韩如泉 (2023) · Figshare · doi:10.6084/m9.figshare.22618615
Yang, Y., Lang, Z., Wang, X., Yang, P., Meng, N., Xing, Y., & Liu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26741870
Yang, Y., Lang, Z., Wang, X., Yang, P., Meng, N., Xing, Y., & Liu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26741861
Yang, Y., Lang, Z., Wang, X., Yang, P., Meng, N., Xing, Y., & Liu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26741843
Yang, Y., Lang, Z., Wang, X., Yang, P., Meng, N., Xing, Y., & Liu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26741867
Kallioinen, M. (2022) · UTUPub (University of Turku)
Estratégias de sedação em contexto pré-hospitalar
Costa, L., Barreira, B., Aguiar, A., Eliseu, A., & Gouveia, A. (2021) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Mascarenhas Chaló, D. D. (2020) · Gredos (University of Salamanca)
Yuan, J., Liang, Z., Geoffrey, M., Xie, Y., Chen, S., Liu, J., Xia, Y., Li, H., Zhao, Y., Mao, Y., et al. (2024) · Dove Medical Press (Taylor and Francis Group)
Varga, S. (2024) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York) · Cited by 1
Nummela, A. J. (2025) · UTUPub (University of Turku)
de Campos-Bandeira, A. (2024) · HAL
Wallner, E., & Handley, B. (2021) · Lund University Publications Student Papers (Lund University)
Schönknecht, N. (2023) · Uppsala University Publications (Uppsala University)
Huang, J. C. (2021) · Digital Commons - USU (Utah State University)
Zhu, Q., Cui, L., Li, X., Li, Q., & Wang, Y. (2025) · Dove Medical Press (Taylor and Francis Group)
Lee, W. X. (2024) · University of Malaya Students Repository
Toro Zuluaga, R. (2025) · Repository Technological University of Pereira (Technological University of Pereira)
Zielinska, B., & Lewandowski, T. (2021) · Pharmaceutical Sciences and Drug Design · doi:10.51847/7jfd5ftyff
Kabalka, E., Smith, Z., Tatem, G. B., & August, B. (2025) · Journal of Intensive Care Medicine · doi:10.1177/08850666251408751
Patrick, R., Birmingham, A. O., Allen, P., & Karelsky, S. (2025) · Laryngoscope Investigative Otolaryngology · doi:10.1002/lio2.70329
“Adverse events associated with propofol include blunting of airway reflexes, hypotension, hypoventilation, and apnea [13].”
Haematophysiological assessment in dogs with propofol anaesthesia during orthopaedic surgery
Agivale, S. M., Salunke, V., Ulemale, A. H., Chauhan, S. A., Mote, C. S., Jadhav, S. N., Shende, T. C., & Aithal, H. (2025) · International Journal of Veterinary Sciences and Animal Husbandry · doi:10.22271/veterinary.2025.v10.i12i.2886
Comparison of Propofol and Midazolam for Sedation in Intensive Care Unit
Muhammad, A., ., A., Saeed, M., Waseem, S. M., Abbas, M. A., & Ali, M. U. (2025) · Pakistan Armed Forces Medical Journal · doi:10.51253/pafmj.v75i6.11169
Pharmacology of Sedation for Noninvasive Ventilator Approaches
Karim, H. M. R. (2025) · Noninvasive ventilation. The essentials · doi:10.1007/978-3-032-05328-2_17
Zhu, Q., Hao, P.-P., Cui, L.-L., Liu, F., & Xue, F.-S. (2026) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s571057
“4,8 Although higher doses generally induce deeper sedation, they concomitantly augment the risks of respiratory depression and hemodynamic suppression.”
Grillot, N., Volteau, C., Quillet, P., Ambrosi, X., Caillard, A., David, J., Blet, A., Bouzat, P., Blanchet, L., Bruneau, N., et al. (2026) · Trials · doi:10.1186/s13063-026-09452-6
“However, its side effect is to induce hypotension due to dose-dependent vasoplegia [14, 15].”
Zhang, M., Schwartz, K., Klukinov, M., Fisher, K. M., Darian‐Smith, C., Franco, B. D., Crowley, M., Huss, M. K., Sharp, P., Jampachaisri, K., et al. (2026) · Journal of the American Association for Laboratory Animal Science · doi:10.30802/aalas-jaalas-25-126
Ma, Y., Zhu, B., Wang, S., Lu, D., Yan, W. C., Yu, Y., Cao, Y., Kang, F., & Li, J. (2026) · Therapeutic Advances in Drug Safety · doi:10.1177/20420986251414580
“8 Nevertheless, its clinical use is often limited by adverse effects such as respiratory depression, hypotension, and injection-associated pain.”
Advantages of Ciprofol with Special Consideration of Pediatric Anesthesia
Vittori, A., Fabio, C. D., Cascella, M., Marinangeli, F., Francia, E., Mascilini, I., Pizzo, C. M., Cecchetti, C., Conza, V. D., Capitello, T. G., et al. (2026) · Children · doi:10.3390/children13020188
“Nevertheless, in clinical practice, propofol has several limitations, including a narrow therapeutic window, dose-dependent cardiovascular and respiratory depression, and a high incidence of pain at the injection site [84].”
Saputra, S., Umaroh, S., & Salomo, S. T. (2024) · Journal of Indonesian Anesthesiology Nursing · doi:10.31101/jian.v1i1.3919
“Selain itu, propofol juga menghambat respon baroreflex fisiologis, sehingga meningkatkan depresi kardiovaskular (Sahinovic et al ., 2018).”
InfluentialSibarani, N. H., Lubis, A. P., Bangun, C. G., & Eyanoer, P. C. (2025) · Jurnal Anestesi Perioperatif · doi:10.15851/jap.v13n3.4454
Zapridis, V., Varkoulis, K., Kirmanidou, G., Tzortzi, I., Kazakos, G. M., Savvas, I., & Anagnostou, T. L. (2026) · Journal of the Hellenic Veterinary Medical Society · doi:10.12681/jhvms.42326
“The anaesthetic properties of propofol are due to its agonistic action on the gamma-aminobutyric acid (GABA) receptor complex by binding to the β-subunit of the GABA A receptor (Sahinovic et al., 2018).”
Gkarmiri, S., Zagalioti, S., Karagiannidis, E., Zagaliotis, P., Stachteas, P., Apostolopoulou, A., Diamantoudis, S. C., Bantidos, M. G., Kofos, C., Kotzampassi, K. E., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15041622
Timing-controlled concept for extubation in brachycephalic dogs: α2–bridged on-demand extubation
Nagahama, S. (2026) · Frontiers in Veterinary Science · doi:10.3389/fvets.2026.1762485
Suganthan, H. (2025) · TSpace (University of Toronto)
Perioperative Anesthetic Strategies in Emergent Neurosurgery During Severe Traumatic Brain Injury
Baloi, D., Rawson, C. D., Montgomery, D., Karsy, M. J., & Pahlevani, M. (2026) · Trauma Care · doi:10.3390/traumacare6010005
“Among available agents, propofol consistently demonstrates the most favorable cerebral profile by lowering CBF, ICP, and cerebral metabolic rate while also preserving autoregulation and CO 2 responsiveness [40,43].”
InfluentialXu, W., Xiao, H., Shi, X., Sun, D., Xu, H., Zhao, C., & Ji, F. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1790750
Protocolo de sedación y analgesia para paciente con ventilación mecánica en Medicina Interna
Hernández, D. A. A. (2024) · Investigative News in Education (Universidad de Costa Rica)
Fentanyl‐Induced Changes in the Cellular Transcriptome of a Person Living With HIV: A Case Report
Roskin, K. M., Meeds, H. L., Krishnan, J. M., Juhascik, M. P., Cafardi, J. M., Brown, J. L., Freiermuth, C. E., Lyons, M. S., Sherman, K. E., & Blackard, J. T. (2026) · Case Reports in Infectious Diseases · doi:10.1155/crdi/9959580
Modulatory role of endogenous adrenaline in propofol-related nociceptive responses in rats
Gözen, F., Sezgin, E. T., Yavuzer, B., Sarigul, C., Mammadov, R., Süleyman, B., Altuner, D., & Süleyman, H. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1773526
“Propofol is an intravenously administered, short-acting hypnotic anesthetic utilized for procedural sedation and for the induction and maintenance of general anesthesia (Dinis-Oliveira, 2018; Sahinovic et al., 2018).”
Zhou, X., Liu, X., Chen, L., Zhao, L., Mao, W., Zhang, L., Xie, Y., & Li, L. (2026) · PeerJ · doi:10.7717/peerj.21018
“…often associated with faster awakening—may permit a rapid return of consciousness at a time when nasal packing, blood/secretions, and airway irritation remain prominent, potentially increasing agitation risk in susceptible patients ( Sahinovic, Struys & Absalom, 2018 ; Schüttler et al., 2020 ).”
Bartkowiak, A. D., & Mooney, M. R. (2026) · Brain Sciences · doi:10.3390/brainsci16030323
“Alternatively, propofol is known to have a rapid clinical metabolism in humans [54], which could explain the weaker transcriptional effects of propofol more broadly in our study.”
Guo, Z., Xiao, Y., Li, X., Wang, Y., Yang, Y., Liu, C., & Liu, W. (2026) · BMC Anesthesiology · doi:10.1186/s12871-026-03767-2
Analgesic and poblational evaluation of acetaminophen
Mengual, C. (2026) · Universidad de Córdoba Insitutional Repository (Universidad de Córdoba)
Saumya, D., Akash, K., Tiwari, D. P. K., Kumari, D., & Roshan, D. R. (2026) · IOSR Journal of Dental and Medical Sciences · doi:10.9790/0853-2501035359
Chen, X., Lai, Y., Shen, Y., Gao, S., Huang, X., Lu, Y., & Xiong, W. (2026) · Drug Design Development and Therapy · doi:10.2147/dddt.s584998
“6 It is widely used for both induction and maintenance of general anesthesia due to its rapid onset, rapid distribution, and quick recovery profile.”
Drishti, A., Dedej, T., Domi, R., Huti, G., Abdyli, A., Hoxha, D., Demiri, O., Filaj, B., Lulaj, D., Lilaj, K., et al. (2026) · Journal of Medical Cases · doi:10.14740/jmc5279
Friedberg, B. L., & Sidemen, I. G. A. E. P. S. (2026) · Bali Journal of Anesthesiology · doi:10.4103/bjoa.bjoa_12_26
Kaya, İ., Deniz, G. Ç., Kocaoglu, M., TOSUN, D. A., & Demirel, A. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48040392
Rohilla, L., Sharma, R., & Tiwari, R. L. (2026) · Bioinformation · doi:10.6026/973206300221840
Kong, S., Li, X. D., Chen, W., Chen, B., Shi, H., Lyu, J., & Wang, Y. (2026) · Drugs & Aging · doi:10.1007/s40266-026-01296-8
王, 思. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1641665
Medications Used for Anaesthesia
Schmidt, C. G. (2026) · Springer eBooks · doi:10.1007/978-3-032-03964-4_16
Perbandingan Keamanan Midazolam dan Propofol sebagai Agen Sedasi pada Prosedur Medis
Kusuma, L. D., Suandika, M., & Surtiningsih (2026) · Jurnal Anestesi · doi:10.59680/anestesi.v4i2.2348
Lee, S. C., Chung, C. J., Ma, S. H., Choi, S. R., Park, S. Y., & Lee, T. Y. (2026) · Anesthesia and Pain Medicine · doi:10.17085/apm.24154
“Many studies have manifested its safety and efficacy for general anesthesia [9,10,12-14].”
Keresztes, M., Azamfirei, L., Almásy, E., & Szederjesi, J. (2026) · Life · doi:10.3390/life16050739
“These microprocessor-driven systems incorporate different pharmacokinetic (PK) and pharmaco-dynamic (PD) models for intravenous anesthetics [3,4] and opioids [5], thereby revolutionizing the practice of total intravenous anesthesia (TIVA) [6,7].”
Alhowary, A. A., Altal, O. F., Hani, D. B., Alrusan, A., Hulliel, A. F., Jadallah, R. K., Alshaykh, R., Dabash, T. Y., Sharie, A. H. A., & Hazaymeh, M. A. (2026) · Journal of Pain Research · doi:10.2147/jpr.s584688
“27 Several studies have demonstrated the anti-inflammatory properties of various general anesthetic agents, such as propofol and volatile anesthetics, which have been shown to attenuate the release of inflammatory cytokines and other mediators.”
Bai, S., Chen, Y., Li, Y., Liu, X., Ba, Y., Chen, Q., Song, X., Zhang, H., Lai, X., Xue, L., et al. (2026) · Cell Biology and Toxicology · doi:10.1007/s10565-026-10195-y
“Propofol is the most commonly administered intravenous anesthetic owing to its rapid onset, efficient metabolism, predictable recovery, and relatively favorable side-effect profile (Sahinovic et al. 2018).”
Chen, Y., Bai, S., Liu, X., Li, Y., Ba, Y., Wang, Y., Zhang, P., Zhang, L., Xue, L., Sun, P., et al. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.111926
Yao, X., Wang, H., Zhang, Y., & Han, J. (2026) · Pharmacology · doi:10.1159/000552425
Lotfy, A. A., Hassan, A., Goda, A. S., Bahr, F. O., Mohamed, J., & baky, D. L. A. E. (2026) · Current anesthesiology reports · doi:10.1007/s40140-026-00707-1
“However, its administration is frequently associated with dose-dependent cardio-respiratory adverse events, particularly hypoxia and hypotension [ 2, 3].”
InfluentialXu, F., Cui, Y., Huang, Y., Tang, J., Xu, Y., Wang, M., Liu, M., Qu, K., Pu, J., Wang, M., et al. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1813849
Dosing Strategies for High-Alert Medications in Obese Pediatric Patients: A Systematic Review
Hernández-Gago, Y., Minagorre, P. J. A., Sánchez‐Hernandez, J. G., Marrodán, B. R., Sabater, L. H., Negrin, A. C. R., & Rodríguez-Suárez, C.-A. (2026) · Pharmaceuticals · doi:10.3390/ph19050766
Moisă, E., & Bilotta, F. (2026) · Revista Española de Anestesiología y Reanimación · doi:10.1016/j.redar.2026.502135
Matsumura, K., Tamura, T., Okumura, K., Kiuchi, R., & Teranishi, H. (2026) · Aesthetic Plastic Surgery · doi:10.1007/s00266-026-05922-z
“Propofol, a commonly used agent for ambulatory sedation, is characterized by rapid onset/ offset and high metabolic clearance, supporting prompt recovery after short procedures [1].”
Popovici, S. E., Ritiu, S. A., Sporea, I., Săndesc, D., Bedreag, O. H., Păpurică, M., & Popescu, A. (2026) · Medicina · doi:10.3390/medicina62061047
“The characteristic U-shaped SE trajectory observed in our cohort—with rapid decline following induction, a nadir near 10 min, and progressive recovery thereafter—reflects the pharmacodynamic profile of propofol during short procedures [7].”
InfluentialNg, M. K. L., Musolino, S. T., Barratt, D. T., Gerstman, M., Riedel, B., Kirkpatrick, C. M. J., & Somogyi, A. A. (2026) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000001474
Li, W., Zhu, M., Xu, W., Cui, W., Li, H., Xue, F., Jin, Z., Chen, C., Yang, B., Sun, M., et al. (2026) · Advances in Therapy · doi:10.1007/s12325-026-03640-1
“Propofol is a potent intravenous hypnotic agent known for its rapid onset and offset of action without accumulation [6].”
Mao, X.-Y., Ye, M.-M., Yu, X.-Y., Liao, J.-T., Hu, Y., Guo, M., Zeng, B., Li, J., Peng, L., Hu, W.-F., et al. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.118510
Kumari, S., Venkatesha, J., Singh, R. B., & Sahu, A. (2026) · Cureus · doi:10.7759/cureus.110220
“Propofol is an intravenous (IV) drug with a rapid onset and short context-sensitive half-time, and its favourable recovery profile and inherent antiemetic effect make it a preferred agent for total intravenous anaesthesia (TIVA) [4].”
Ajithkumar, M., & GOANKAR, S. (2026) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2026v19i6.59516
Metadata
- Authors
- Sahinovic, M. M., Struys, M. M. R. F., & Absalom, A. R.
- Affiliations
- University Medical Center Groningen (NL)
- Corresponding author
- Sahinovic, Marko M.
- Venue
- Clinical Pharmacokinetics
- Published
- 2018-07-18
- Volume
- 57
- Issue
- 12
- Pages
- 1539-1558
- ISSN
- 0312-5963 (ISSN-L)
- 1179-1926
- PMC
- PMC6267518
- OpenAlex
- W2883595456
- Cited by
- 809
- References
- 201
- Citations by year
- 2026: 132 · 2025: 148 · 2024: 140 · 2023: 136 · 2022: 103 · 2021: 66 · 2020: 60 · 2019: 19 · 2018: 2
- FWCI
- 9.03
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0 (tdm)
- Locations
- Clinical Pharmacokinetics (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion, cc-by-nc)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by-nc)
- Topics
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
- Health Sciences › Veterinary › Small Animals › Veterinary Pharmacology and Anesthesia
- Health Sciences › Medicine › Physiology (medical) › Biomedical and Chemical Research
- Keywords
- propofol, pharmacokinetics, pharmacodynamics, general anesthesia, target-controlled infusion, pharmacokinetic modeling, pharmacodynamic modeling, drug interactions, hypnotics, opioid synergy, response surface modelling, adverse effects, drug dosing
- MeSH terms
- Adult, Animals, Child, Dose-Response Relationship, Drug, Drug Interactions, Humans, Hypnotics and Sedatives, Models, Biological, Obesity, Propofol, Anesthetics, Intravenous
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

